ANTABUSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Antabuse, and when can generic versions of Antabuse launch?
Antabuse is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.
The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Antabuse
A generic version of ANTABUSE was approved as disulfiram by SIGMAPHARM LABS LLC on March 28th, 2011.
Summary for ANTABUSE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 25 |
Patent Applications: | 515 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANTABUSE at DailyMed |
Recent Clinical Trials for ANTABUSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universidad de Guanajuato | Early Phase 1 |
Laboratorios Doctor Macías | Early Phase 1 |
University of California, San Francisco | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for ANTABUSE
US Patents and Regulatory Information for ANTABUSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088482-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088483-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |